Lindsey Roeker

[Lindsey Roeker @LRoekerMD]

Thrilled to be at @AACR presenting the first look at phase 1B data on pirtobritinib / ven +/- ritux - well tolerated with ORR of 96% with median f/u of 9 months! Thanks to all of the BRUIN investigators and patients for making this possible @anthonymatomd @MSKHemOncTrials

[ACCC @ACCCBuzz]

On April 5 at 2pm EDT, attend this ACCC webinar to better understand #biomarker testing in patients with #hematologic #malignancies. Learn best practices for biomarker testing in #ChronicLymphocyticLeukemia (#CLL) and #MultipleMyeloma. Register at: https://t.co/hJthx4QaOu

[Lindsey Roeker @LRoekerMD]

@VincentRK Sincerely hope we can catch up at a meeting soon! Hope you are doing well!

[Lindsey Roeker @LRoekerMD]

Wishing I could be at #ASH21 in person, but COVID had different plans. SO grateful for tech solutions that allow for virtual engagement!

[Lindsey Roeker @LRoekerMD]

@RedMedEd @UjjaniC @drjoannarhodes1 @TarunWasil And of course, thanks @lymphoma!!

[Lindsey Roeker @LRoekerMD]

@RedMedEd Thank you @RedMedEd for organizing such an awesome Friday symposium! And thank you @UjjaniC and @drjoannarhodes1 and @TarunWasil for all of your hard work in making the session a success!

[Lindsey Roeker @LRoekerMD]

@UjjaniC @drjoannarhodes1 @CllSociety @SeattleCCA @fredhutch Couldn’t agree more!!

[Lindsey Roeker @LRoekerMD]

Looking for an opportunity to join in our pursuit to bring outstanding and cutting edge care to patients with CLL and other blood cancers in Commack (Long Island) as a clinical trial nurse in the outpatient setting? Would love to meet you! @anthonymatomd
https://t.co/Y8VE0aaRYe

[Toby Eyre @tobyeyre82]

Thanks to @BloodJournal for highlighting our work! with @anthonymatomd + @LRoekerMD

COVID-19 in patients with CLL: how can we change the odds? | Blood | American Society of Hematology https://t.co/CY1Iw4UlNB

[Mazyar Shadman, MD MPH @mshadman]

We recommend #vaccinationCovid for all #CLL pts. We also need to study the efficacy of vaccine in pts on novel agents. We have discussed the topic in Bood: https://t.co/q1jUkOguTB

We are also actively studying this at @fredhutch @SeattleCCA @UWMedicine
@UjjaniC @Rcl14L

[Lindsey Roeker @LRoekerMD]

Happy to be joining @CancerCare for an Update on CLL on March 25! For more information or to register, please visit https://t.co/gLT0CKMCil

[Lindsey Roeker @LRoekerMD]

Has anyone seen blebbing of neutrophil cytoplasm with toxic granulations when reviewing peripheral smears for COVID19 patients?? #COVID19 #hematology @anthonymatomd @tobyeyre82

[Lindsey Roeker @LRoekerMD]

Grateful for @anthonymatomd mentorship and this opportunity to better understand a gap in the literature #ash19 @sloan_kettering

[Toby Eyre @tobyeyre82]

This must be a research first?! #CLL #ASH19

[Lindsey Roeker @LRoekerMD]

So excited to see this data presented, which represents how much can be accomplished when we work together! @anthonymatomd @tobyeyre82 @UjjaniC @calliecoombsmd #ASH19

[Lindsey Roeker @LRoekerMD]

@anthonymatomd presenting exciting data on LOXO-305 - well tolerated and effective, even in patients with BTK C481 mutations @MSKCC_OncoNotes #ASH2019

[Lindsey Roeker @LRoekerMD]

Excited to bring #VenetoSTOP to the clinic - an opportunity to use biology as the guide for treatment duration!

[Lindsey Roeker @LRoekerMD]

@anthonymatomd @sloan_kettering Thank you for the warm welcome! Hi Twitterverse!